Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Short term Debt (2023 - 2024)

Tonix Pharmaceuticals Holding (TNXP) has 2 years of Short term Debt data on record, last reported at $2.8 million in Q4 2024.

  • For Q4 2024, Short term Debt rose 20.0% year-over-year to $2.8 million; the TTM value through Dec 2024 reached $2.8 million, up 20.0%, while the annual FY2024 figure was $2.8 million, 20.0% up from the prior year.
  • Short term Debt reached $2.8 million in Q4 2024 per TNXP's latest filing, roughly flat from $2.8 million in the prior quarter.
  • Across five years, Short term Debt topped out at $2.8 million in Q1 2024 and bottomed at $2.4 million in Q4 2023.